- Home
- INM vs HKPD Comparison
INM vs HKPD Comparison
Compare INM & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INM | HKPD |
|---|---|---|
| Founded | 1981 | 2016 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 6.2M |
| IPO Year | 2020 | 2024 |
Fundamental Metrics
Financial Performance| Metric | INM | HKPD |
|---|---|---|
| Price | $1.35 | $0.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 52.7K | ★ 1.4M |
| Earning Date | 11-05-2026 | 08-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.68 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,942,633.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.58 | $0.10 |
| 52 Week High | $2.50 | $1.68 |
Technical Indicators
Market Signals| Indicator | INM | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 44.37 | 28.19 |
| Support Level | $1.25 | $0.10 |
| Resistance Level | $1.40 | $0.70 |
| Average True Range (ATR) | 0.06 | 0.01 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 35.28 | 68.17 |
Price Performance
Historical ComparisonAbout INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.